Administrative Core
Administrative Core
批准号:
10117260
负责人:
CHARLES A O'BRIEN
金额:
$49.51万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-16 至 2023-01-31
关键词:
Advisory CommitteesApplications GrantsAreaArkansasBioinformaticsBone remodelingBreast cancer metastasisCenters of Research ExcellenceChildData SetDegenerative polyarthritisDevelopmentDevelopment PlansDiseaseEvaluationExtramural ActivitiesFacultyFaculty RecruitmentFosteringFundingGenetic ModelsGoalsGrowthHealthcare SystemsInfrastructureInstitutionInternationalLeadershipMeasuresMedicalMentorsMentorshipMetastatic Neoplasm to the BoneMolecularMultiple MyelomaMusculoskeletalMusculoskeletal DiseasesMusculoskeletal SystemNeoplasm MetastasisOsteomyelitisOsteoporosisPathologic ProcessesPeer ReviewPilot ProjectsProcessPublicationsPublishingResearchResearch InstituteResearch PersonnelResearch Project GrantsScienceServicesSkeletal DevelopmentSystemTeacher Professional DevelopmentUnited States National Institutes of HealthUniversitiesVeteransbaseeffective therapyexperiencemembermultidisciplinarynovel therapeuticsoperationprogramsranpirnaserecruitresearch and developmentskeletalskeletal tissuesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall goal of this application is to establish a thematic, multidisciplinary Center for Musculoskeletal Disease
Research at the University of Arkansas for Medical Sciences (UAMS) via the COBRE mechanism. This will be
a self-sustaining research center focused on identifying the molecular causes of diseases and conditions that
negatively impact the musculoskeletal system or interact with this system as part of their disease process.
Successfully establishing this COBRE will spur the development of new and effective therapies for a broad range
of conditions, including osteoporosis, osteoarthritis, aberrant skeletal development, osteomyelitis, multiple
myeloma, and cancer metastases to the bone. A key to the success of this Center will be the development of
new independent investigators who are committed to team-based musculoskeletal research. To develop and
operate this Center, the Administrative Core will establish the scientific and administrative infrastructure
necessary to meet the needs of musculoskeletal researchers at UAMS and affiliated institutions and will oversee
all organizational and budgetary aspects of Center development and function (Specific Aim 1). The
Administrative Core will also implement a faculty development plan that will mentor four junior investigators to
the point of independence, as measured by obtaining R01-level funding, and beyond (Specific Aim 2). The
Administrative Core will support the growth of the Center by recruiting and promoting the development of new
junior investigators to replace those that achieve independence via a pilot project program, the targeted
recruitment of new investigators, and by effective Center evaluation (Specific Aim 3). These goals will be
accomplished under the leadership of the Center Director who, with the support of experienced mentors and an
Internal and External Advisory Committee, will guide four Project Leaders focused on musculoskeletal research
to independence. The Administrative Core will also oversee the operation of three Research Cores providing
state-of-the-art services to create new genetic models (Core B), perform specialized skeletal tissue analysis
(Core C), and perform bioinformatic analyses of large molecular datasets (Core D). The overall success of this
strategy will be gauged by achieving the following milestones within the first five years of Center funding: 1) three
or more of the Project Leaders will successfully compete for NIH or federal R01-level research grant support to
graduate to independent investigator status; 2) two to four new Project Leaders (and Mentors) will be selected
and join the Center; 3) Project Leaders and other Center members will publish between 20 and 30 peer-reviewed
publications; and 4) graduated Project Leaders and other members of the Center will be in the process of
developing, or will have submitted, a center-level grant application, such as a P01 or P30.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Models
-
批准号:10357774
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Center for Musculoskeletal Disease Research (CMDR)
-
批准号:10357772
-
项目类别:
-
资助金额:$227.44万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Administrative Core
-
批准号:10357773
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Administrative Core
-
批准号:10495742
-
项目类别:
-
资助金额:$58.84万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Genetic Models
-
批准号:10117261
-
项目类别:
-
资助金额:$19.04万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Center for Musculoskeletal Disease Research (CMDR)
-
批准号:10495741
-
项目类别:
-
资助金额:$229.5万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Center for Musculoskeletal Disease Research (CMDR)
-
批准号:10117257
-
项目类别:
-
资助金额:$227.44万
-
财政年份:2018
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and lymphocyte-mediated bone loss
-
批准号:9275307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and lymphocyte-mediated bone loss
-
批准号:8633709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and Inflammation-associated Bone Loss
-
批准号:8258635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and Inflammation-associated Bone Loss
-
批准号:7687062
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Molecular mechanisms of glucocorticoid-induced bone loss
-
批准号:10084209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and Inflammation-associated Bone Loss
-
批准号:8195622
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
RANKL and Inflammation-associated Bone Loss
-
批准号:7782821
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHARLES A O'BRIEN
-
依托单位:
TRANSGENIC MOUSE CORE
-
批准号:7094987
-
项目类别:
-
资助金额:$10.84万
-
财政年份:2006
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Osteocyte Control of Bone Remodeling
-
批准号:10442181
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2003
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Osteocyte Control of Bone Remodeling
-
批准号:9236157
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2003
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Molecular Control of RANKL Gene Expression
-
批准号:7877808
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2003
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Molecular Control of RANKL Gene Expression
-
批准号:7663135
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2003
-
负责人:CHARLES A O'BRIEN
-
依托单位:
Osteocyte Control of Bone Remodeling
-
批准号:8880756
-
项目类别:
-
资助金额:$32.78万
-
财政年份:2003
-
负责人:CHARLES A O'BRIEN
-
依托单位: